Universal Beteiligungs und Servicegesellschaft mbH Invests $468,000 in Bausch Health Companies Inc. (NYSE:BHC)

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Bausch Health Companies Inc. (NYSE:BHC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 57,970 shares of the company's stock, valued at approximately $468,000.

A number of other hedge funds have also recently made changes to their positions in the business. Tobam lifted its position in shares of Bausch Health Companies by 10.4% in the fourth quarter. Tobam now owns 15,034 shares of the company's stock worth $121,000 after buying an additional 1,422 shares in the last quarter. Principal Securities Inc. lifted its position in shares of Bausch Health Companies by 39.7% in the fourth quarter. Principal Securities Inc. now owns 19,220 shares of the company's stock worth $155,000 after buying an additional 5,464 shares in the last quarter. Handelsbanken Fonder AB lifted its position in shares of Bausch Health Companies by 18.4% in the fourth quarter. Handelsbanken Fonder AB now owns 65,100 shares of the company's stock worth $525,000 after buying an additional 10,100 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Bausch Health Companies by 1.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,284,036 shares of the company's stock worth $10,375,000 after buying an additional 14,558 shares in the last quarter. Finally, Aigen Investment Management LP purchased a new stake in shares of Bausch Health Companies in the fourth quarter worth about $180,000. Institutional investors own 78.65% of the company's stock.

Bausch Health Companies Trading Up 2.6%

Shares of NYSE BHC traded up $0.12 during trading on Friday, reaching $4.75. 991,688 shares of the company traded hands, compared to its average volume of 2,553,351. The firm's fifty day simple moving average is $4.85 and its 200 day simple moving average is $6.52. The stock has a market cap of $1.74 billion, a P/E ratio of -39.58, a PEG ratio of 0.37 and a beta of 0.34. Bausch Health Companies Inc. has a 12-month low of $3.96 and a 12-month high of $9.85.

Analysts Set New Price Targets

BHC has been the topic of a number of research analyst reports. Wall Street Zen downgraded Bausch Health Companies from a "buy" rating to a "hold" rating in a research report on Saturday, May 10th. Royal Bank of Canada boosted their target price on Bausch Health Companies from $8.50 to $10.00 and gave the stock a "sector perform" rating in a research report on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating and seven have issued a hold rating to the stock. According to data from MarketBeat, Bausch Health Companies currently has an average rating of "Hold" and a consensus price target of $7.42.

Bausch Health Companies Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.